Medifast, Inc.
MED
$13.48
$0.29242.22%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 421.24% | -196.38% | -28.93% | 113.82% | -198.04% |
| Total Depreciation and Amortization | 23.32% | -73.49% | 306.39% | -295.50% | -5.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.29% | 120.12% | -203.78% | -33.31% | 2,395.18% |
| Change in Net Operating Assets | -512.79% | 63.76% | -514.27% | 219.74% | 80.58% |
| Cash from Operations | -199.18% | 168.85% | -154.53% | -30.58% | 79.47% |
| Capital Expenditure | 9.46% | 33.39% | -64.39% | 28.28% | -5.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,869.74% | 96.90% | -4,273.98% | 34.01% | 36.40% |
| Cash from Investing | 750.29% | 89.43% | -990.40% | 29.62% | 8.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 99.73% | -36,800.00% | 50.00% | 87.50% | 98.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 99.48% | -- | 100.00% | 75.00% | 99.44% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 99.64% | -56,200.00% | 66.67% | 85.00% | 98.66% |
| Foreign Exchange rate Adjustments | -- | -- | -100.00% | -85.71% | 86.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,164.51% | 103.24% | -434.37% | -30.86% | 247.90% |